Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,055Revenue $M38.8Net Margin (%)-248.1Altman Z-Score33.5
Enterprise Value $M1,741EPS $-0.4Operating Margin %-248.9Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-248.1Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %-0.6Quick Ratio12.3Cash flow > EarningsY
Price/Sales48.55-y EBITDA Growth Rate %-3.8Current Ratio12.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-27.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-30.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M270ROIC % (ttm)-113.4Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVAXFirst Eagle Investment 2014-12-31 Sold Out -0.01%$4.05 - $5.98
$ 7.6246%Sold Out0
NVAXFirst Eagle Investment 2014-06-30 Add$3.69 - $5.13
$ 7.6274%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
$ 7.6236%Sold Out0
NVAXFirst Eagle Investment 2014-03-31 Reduce-0.01%$4.13 - $6.65
$ 7.6236%Reduce 75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
$ 7.62117%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
$ 7.62117%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
$ 7.62170%New holding573,000
NVAXFirst Eagle Investment 2013-09-30 Buy 0.01%$2.25 - $3.39
$ 7.62170%New holding800,000
NVAXFirst Eagle Investment 2011-03-31 Sold Out $2.15 - $2.96
$ 7.62212%Sold Out0
NVAXFirst Eagle Investment 2010-09-30 Add$2.01 - $2.34
$ 7.62246%Add 25.00%125,000
NVAXFirst Eagle Investment 2010-06-30 Reduce$2.18 - $2.97
$ 7.62210%Reduce 52.65%100,000
NVAXFirst Eagle Investment 2009-12-31 Buy 0.01%$2.53 - $4.41
$ 7.62120%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EVANS GARY CDirector 2015-08-24Sell20,000$11.24-32.21view
PHILLIPS BARCLAY ASVP, CFO 2015-08-20Sell28,656$13.06-41.65view
Glenn Gregory MSVP, Research and Development 2015-08-18Sell15,000$13.52-43.64view
EVANS GARY CDirector 2015-08-13Sell6,002$13.56-43.81view
Trizzino JohnSVP, Commercial Operations 2015-07-31Buy5,098$3.63109.92view
Herrmann John A IIISVP, General Counsel 2015-07-31Buy1,502$2.28234.21view
Glenn Gregory MSVP, Research and Development 2015-07-31Buy892$2.28234.21view
PHILLIPS BARCLAY ASVP, CFO 2015-07-31Buy764$2.28234.21view
Erck Stanley CCEO and President 2015-07-31Buy3,207$2.28234.21view
YOUNG JAMES FDirector 2015-06-18Sell50,000$9.47-19.54view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
comment on NVAX Mar 16 2013 
comment on NVAX Mar 16 2013 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
creiter note on NVAX Jan 03 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 

More From Other Websites
Novavax Announces Management Promotion Oct 01 2015
Novavax, Inc. Earnings Q2, 2015 Oct 01 2015
Novavax Granted Up to $89 Million for RSV Vaccine Sep 30 2015
Novavax's Respiratory Vaccine Study Data Fail to Impress Sep 30 2015
NOVAVAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Sep 30 2015
Portola Pharmaceuticals Rose 14.33% Last Week Sep 30 2015
Which of These Two Trending Stocks Hedge Funds Like More? Sep 30 2015
Jim Cramer's Top Takeaways: Novavax and Exxon Mobil Sep 30 2015
Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud Sep 29 2015
Cramer Remix: This could push oil even higher Sep 29 2015
Novavax Falls as Respiratory Vaccine Results Don't Impress Sep 29 2015
NOVAVAX INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Sep 29 2015
Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics Sep 29 2015
Novavax RSV vaccine found safe for pregnant women, fetus Sep 29 2015
UPDATE 1-Novavax RSV vaccine given to mothers safe for fetus-study Sep 29 2015
Novavax RSV vaccine given to mothers safe for fetus - study Sep 29 2015
Novavax Rekindles Positive Momentum With RSV and Gates Grant Sep 29 2015
Novavax to Host 3rd Annual Analyst and Investor Meeting - Sep 29 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)